Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease

儿童疫苗对预防 1 型糖尿病、自身免疫性甲状腺疾病和乳糜泻的有益作用

基本信息

  • 批准号:
    10482378
  • 负责人:
  • 金额:
    $ 19.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-06 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Viral infections have long been hypothesized to be triggers for childhood autoimmune conditions, but the benefit of childhood vaccines for prevention of such diseases is uncertain. Studies focusing upon such benefits are critical due to the rising rates of vaccine deferral in the U.S and the lowered rates of pediatric vaccination due to the COVID pandemic. This is a resubmission for PA-18741 R21 Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases. Our goal is to examine whether measles, mumps, and rubella vaccine (MMR) and rotavirus vaccine (RV) protect children from developing 3 associated autoimmune diseases during childhood: type 1 diabetes (T1D), celiac disease, and autoimmune thyroid disease. Congenital rubella increases pancreatic islet cell autoantibody production, and we and others have reported that congenital rubella infection increases risk for T1D. Congenital rubella infection is also associated with anti- thyroglobulin antibody, a precursor of autoimmune thyroid disease. MMR appears to induce heterologous as well as trained T-cell responses, thus conferring immunity that is polymicrobial as well as protection against measles, mumps, and rubella. Therefore, MMR may plausibly protect against triggers for autoimmune disease, but existing studies are relatively few and underpowered. Along similar lines, we and others have reported that RV protects against T1D, possibly by interfering with auto-immunization caused by molecular mimicry. Among persons at high risk for T1D, RV also protects against childhood celiac disease. It is uncertain whether RV protects against celiac disease in a broad population, and whether RV protects against autoimmune thyroid disease. To address these knowledge gaps, we propose to examine the protective effects of MMR for childhood T1D, celiac disease, and autoimmune thyroid disease as well as RV for celiac disease and autoimmune thyroid disease in the national, longitudinally-integrated health insurance database that we used in our previous studies (n=1,474,535). Aim 1 is to examine whether MMR decreases risk of early childhood T1D; we hypothesize that infants who receive MMR will have lower risk compared to unvaccinated infants. Aim 2 is to examine whether MMR and RV decrease risk of early childhood celiac disease. We hypothesize that infants who receive MMR or RV will have lower risk compared to unvaccinated infants. Aim 3 is to examine whether MMR and RV decrease risk of early childhood autoimmune thyroid disease. We hypothesize that infants who receive MMR or RV will have lower risk compared to unvaccinated infants. It is unethical to conduct clinical trials to establish the impact of vaccines upon autoimmune disease, but studies focusing upon autoimmune disease prevention are under-powered. Therefore, carefully conducted observational studies are needed which examine the benefits of vaccines for such diseases. Such benefits may prove to be a compelling motivator to vaccinate for the vaccine-hesitant. Due to our expertise in epidemiology, statistical analysis of complex relational data, and familiarity with the datasets, we can efficiently conduct this high-impact work.
长期以来,病毒感染一直是儿童自身免疫性疾病的触发因素,但 儿童期疫苗预防这种疾病的益处尚不确定。研究重点的研究 由于美国递延疫苗递延率的上升和小儿疫苗接种率降低而至关重要 由于共同的大流行。 这是重新提交的 PA-18741 R21肥胖中的次要分析, 糖尿病,消化和肾脏疾病。我们的目标是检查麻疹,腮腺和风疹是否 疫苗(MMR)和轮状病毒疫苗(RV)保护儿童免受3种相关的自身免疫性 儿童期疾病:1型糖尿病(T1D),乳糜泻和自身免疫性甲状腺疾病。先天性 风疹增加胰岛细胞自身抗体的产生,我们和其他人报告说 先天性风疹感染增加了T1D的风险。先天性风疹感染也与 甲状腺球蛋白抗体,自身免疫性甲状腺疾病的前体。 MMR似乎诱导异源 以及受过训练的T细胞反应,因此赋予多数菌和保护的免疫力 麻疹,腮腺炎和风疹。因此,MMR可能可能预防自身免疫性疾病的触发因素, 但是现有的研究相对较少且功能不足。同样,我们和其他人报告说 RV可以通过干扰分子模仿引起的自身免疫来预防T1D。之中 RV患有T1D高风险的人也可以防止儿童腹腔疾病。不确定RV是否 在广泛人群中预防腹腔疾病,以及RV是否可以防止自身免疫性甲状腺 疾病。为了解决这些知识差距,我们建议检查MMR的保护作用 儿童时期T1D,乳糜泻和自身免疫性甲状腺疾病以及乳糜泻的RV 我们使用的国家纵向健康保险数据库中的自身免疫性甲状腺疾病 在我们以前的研究中(n = 1,474,535)。目标1是检查MMR是否降低了幼儿的风险 t1d;我们假设与未接种疫苗的婴儿相比,接受MMR的婴儿的风险将较低。目的 2是检查MMR和RV是否会降低儿童早期腹腔疾病的风险。我们假设这一点 与未接种疫苗的婴儿相比,接受MMR或RV的婴儿的风险较低。目标3是检查 MMR和RV是否会降低儿童早期自身免疫性甲状腺疾病的风险。我们假设这一点 与未接种疫苗的婴儿相比,接受MMR或RV的婴儿的风险较低。这是不道德的 进行临床试验以确立疫苗对自身免疫性疾病的影响 预防自身免疫性疾病的动力不足。因此,经过精心进行的观察性研究是 需要检查疫苗对此类疾病的好处。这种好处可能被证明是一个引人注目的 为疫苗疫苗接种疫苗的动力。由于我们在流行病学方面的专业知识,统计分析 复杂的关系数据以及对数据集的熟悉,我们可以有效地进行这项高影响力的工作。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CATHERINE KIM其他文献

CATHERINE KIM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CATHERINE KIM', 18)}}的其他基金

Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
  • 批准号:
    10930196
  • 财政年份:
    2023
  • 资助金额:
    $ 19.5万
  • 项目类别:
Gestational diabetes and offspring aging and metabolism
妊娠期糖尿病与后代衰老和代谢
  • 批准号:
    10425757
  • 财政年份:
    2022
  • 资助金额:
    $ 19.5万
  • 项目类别:
Gestational diabetes and offspring aging and metabolism
妊娠期糖尿病与后代衰老和代谢
  • 批准号:
    10577849
  • 财政年份:
    2022
  • 资助金额:
    $ 19.5万
  • 项目类别:
Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
儿童疫苗对预防 1 型糖尿病、自身免疫性甲状腺疾病和乳糜泻的有益作用
  • 批准号:
    10367489
  • 财政年份:
    2021
  • 资助金额:
    $ 19.5万
  • 项目类别:
ReproEDIC: Risk and Progression of Reproductive Abnormalities in Type 1 Diabetes
ReproEDIC:1 型糖尿病生殖异常的风险和进展
  • 批准号:
    8477599
  • 财政年份:
    2013
  • 资助金额:
    $ 19.5万
  • 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
  • 批准号:
    7983696
  • 财政年份:
    2010
  • 资助金额:
    $ 19.5万
  • 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
  • 批准号:
    8098763
  • 财政年份:
    2010
  • 资助金额:
    $ 19.5万
  • 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
  • 批准号:
    8278068
  • 财政年份:
    2010
  • 资助金额:
    $ 19.5万
  • 项目类别:
A pilot lifestyle intervention for women with histories of GDM: The PEG Study
针对有 GDM 病史的女性的试点生活方式干预:PEG 研究
  • 批准号:
    7770845
  • 财政年份:
    2009
  • 资助金额:
    $ 19.5万
  • 项目类别:
A pilot lifestyle intervention for women with histories of GDM: The PEG Study
针对有 GDM 病史的女性的试点生活方式干预:PEG 研究
  • 批准号:
    7637097
  • 财政年份:
    2009
  • 资助金额:
    $ 19.5万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
  • 批准号:
    10822202
  • 财政年份:
    2024
  • 资助金额:
    $ 19.5万
  • 项目类别:
Leveraging COVID-19 to modernize depression care for VA primary care populations
利用 COVID-19 实现 VA 初级保健人群的抑郁症护理现代化
  • 批准号:
    10636681
  • 财政年份:
    2023
  • 资助金额:
    $ 19.5万
  • 项目类别:
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
  • 批准号:
    10495114
  • 财政年份:
    2023
  • 资助金额:
    $ 19.5万
  • 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
  • 批准号:
    10456380
  • 财政年份:
    2023
  • 资助金额:
    $ 19.5万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 19.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了